TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05937854: Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Sponsor: VA Office of Research and Development · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 126 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$3,652,000

Rescue Site Savings

+$2,423,600

Unlock Full NCT05937854 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05937854 Rescue Dossier →